Nuclear Medicine and Molecular Imaging Essentials 2019

Quantity must be 1 or more

Session 1: Oncologic Imaging

Prostate Cancer Metastases: New Diagnostic Tools and Treatment	Olga Mochanova-Cook, MD, PhD
State of the Art PET/MRI Applications in Nucear Oncology	Ali Civelek, MD
Molecular Imaging of Indeterminate Renal Masses	Steven Rowe, MD
CAR T-Cell Therapy and Role of Molecular Imaging in Monitoring the Sourse of Treatment	Reza Sirous, MD

Session 2: Neuro

The Evolving Role of PET/CT for Neuroendocrine Tumor Imaging	Daniel Pryma, MD
Management of Patients With Neuroendocrine Cancers in the Era of Ga68 and Lu177	Petr Hausner, MD
Technical Aspects and Logistics of Lu-177 Therapy in Functional Neuro Endocrine Tumors	Ali Civelek, MD
Imaging and Therapy of Pheochromocytoma/Paraganglioma	Daniel Pryma, MD
Comparison of 18F-FDG PET/CT and MRI in the Evaluation of Patients With Antibody Positive Autoimmune Encephalitis	Krystyna Jones, MD

Session 3: Cardiac Imaging

Cardiac Sarcoidosis and Amyloidosis Imaging	Panithaya Chareonthaitawee, MD
Evolving Role of PET in Assessing Atherosclerosis and Other Vascular Disorders	Abass Alavi, MD
Cardiac Device Infection Imaging	Wengen Chen, MD, PhD, FACNM

Session 4: Past, Present and Future Applications

Impacts of Infiltration in PET/CT	James Crowley, MHA, CNMT
Gastroesophageal Scintigraphy: Milk Scan and Salivagram	Hongming Zhuang, MD
USP 727 and 825	Richard Green, BSPharm, RPh, BCNP, FAPhA
18F-FDG-PET Imaging’s Contributions to Medicine	Abass Alavi, MD
New SiPM-based PET Systems	Mark F. Smith, PhD, DABSNM
Case Studies	Mark Crosthwaite, M.Ed, CNMT, PET, FSNMMI-TS

Release Date: 8/20/19
CME Expiration: 8/19/22

Welcome Newcomer